Nebenwirkungen · Enbrel
Enbrel 25 mg powder for solution for injection · Abschnitt 4.8 · PDF-Seite 11
HOS-090259 · Präparat HOS-084041
System Organ Very Common Uncommon Rare Very Not Known Class Common ≥ 1/100 to ≥ 1/1,000 to ≥ 1/10,000 to Rare (Cannot be ≥ 1/10 < 1/10 < 1/100 < 1/1,000 < 1/10,000 Estimated from Available Data) Infections and Infection Serious infections Tuberculosis, Hepatitis B infestations (including (including opportunistic reactivation, listeria upper pneumonia, infection (including respiratory cellulitis, arthritis invasive fungal, tract bacterial, sepsis protozoal, bacterial, infection, and parasitic atypical bronchitis, infection)* mycobacterial, viral cystitis, infections, and skin Legionella)* infection)* Neoplasms Non-melanoma Malignant Merkel cell benign, skin cancers* (see melanoma (see carcinoma (see malignant and section 4.4) section 4.4),
Originalpassage; keine automatisch abgeleitete Schwere, Häufigkeit oder Kausalität. Auch verneinte Befunde und nicht untersuchte Kombinationen bleiben sichtbar.
Vollständigen Kontext in der EMA-Fachinformation lesen →Quellennachweis
Version 2025-08-13T14:40:00Z · SHA-256 2c6500390fb2c4d6c023708f4ad5e87e0680d81ce838cfcbebc32899e1a4b8e3 · Passage 82469a8813f1a28b30040734f7e27a6b8f5a391b9c30dc9fa41cf59a6dd4eea5 · Zeichen 1793–3452 im Abschnitt